CLINICAL PRACTICE CONSIDERATIONS Long-term outcomes While strong evidence supports the kidney-protective effects of both SGLT2 inhibitors and GLP-1 receptor agonists, the long-term durability of these benefits remains uncertain (Table 2)
Trials have initiated treatment at a lower dose, with scheduled increases every four weeks to allow for monitoring of tolerability and side effects
GLUTATHIONE GLOW SET Your skin deserves to shine with confidence, clarity & glow
Helps support healthy cell development.*
While the primary benefits of glutathione are related to its antioxidant and cellular protective properties, some users claim additional skin benefits
According to Rudkowska and Jones (2007), the maximum safe dosage of MCT in young children, pregnant or nursing women, or people with serious kidney disease has not been firmly established